Kompass
1 known investors
Kompass develops a rapid hormone diagnostic analyzer for point-of-care testing in fertility treatment. The platform delivers hormone test results in approximately 10 minutes from whole blood samples, targeting healthcare providers involved in fertility care.
FemTechHealthtechMedical Devices